Hong Kong Pharmaceuticals & Biotech Stocks

  • 7D-1.2%
  • 1Y42.5%
  • Avg. PE13.9x
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield
1177Sino BiopharmaceuticalHK$8.203.7%3.0%HK$154.0bHK$10.87P/E46.2xE16.4%1.0%
1093CSPC Pharmaceutical GroupHK$9.873.1%22.7%HK$118.6bHK$12.76P/E19xE9.5%1.8%
1548Genscript BiotechHK$19.648.6%24.9%HK$38.0bHK$21.36P/S12.3xE56.5%0%
9966Alphamab OncologyHK$17.6420.8%-5.3%HK$17.1bHK$19.41P/S303.7xE31.2%n/a
1801Innovent BiologicsHK$82.401.4%108.1%HK$124.2bHK$104.66P/S24.2xE49.6%n/a
6855Ascentage Pharma Group InternationalHK$44.2015.4%47.3%HK$10.9bHK$55.72P/S634.4xE26.8%n/a
15303SBioHK$7.567.4%-14.1%HK$19.1bHK$10.64P/E19.1xE16.1%0%
9939Kintor PharmaceuticalHK$66.603.9%n/aHK$24.4bHK$47.75P/B11.4xE75.3%n/a
512China Grand Pharmaceutical and Healthcare HoldingsHK$6.682.8%16.8%HK$23.1bHK$10.00P/E12.8xS17.6%1.6%
2186Luye Pharma GroupHK$4.753.9%20.3%HK$16.7bHK$5.74P/E17.7xE19.9%0%
2877China Shineway Pharmaceutical GroupHK$6.3412.4%18.3%HK$4.4bHK$8.13P/E13.5xE22.0%6.1%
3933United Laboratories International HoldingsHK$6.704.4%-6.4%HK$12.3bHK$8.47P/E14xE16.6%1.4%
1952Everest MedicinesHK$67.501.9%n/aHK$19.1bHK$106.65n/aE79.7%n/a
2161JBM (Healthcare)HK$1.8028.6%n/aHK$1.6bn/aP/E31.7xn/an/a
6118Austar LifesciencesHK$8.827.8%96.0%HK$4.4bn/aP/E113.1xn/a0%
2005SSY GroupHK$4.941.9%-5.4%HK$15.7bHK$5.62P/E24.5xE27.9%2.0%
1681Consun Pharmaceutical GroupHK$4.985.1%24.5%HK$4.0bHK$8.47P/E6.8xE12.2%5.6%
1558YiChang HEC ChangJiang PharmaceuticalHK$6.961.3%-51.8%HK$5.9bHK$11.63P/E6xE4.2%0%
2348Dawnrays Pharmaceutical (Holdings)HK$1.583.3%38.6%HK$2.3bn/aP/E7.6xn/a4.1%
1349Shanghai Fudan-Zhangjiang Bio-PharmaceuticalHK$4.881.5%1.7%HK$16.6bn/aP/E22xn/a1.2%
1643Modern Chinese Medicine GroupHK$1.0413.0%n/aHK$522.0mn/aP/E6.1xn/an/a
2552Hua Medicine (Shanghai)HK$4.890.8%57.7%HK$4.6bHK$11.41P/S444xE68.9%n/a
719Shandong Xinhua PharmaceuticalHK$4.680.4%15.8%HK$5.7bn/aP/E7.2xn/a3.9%
1875TOT BIOPHARM InternationalHK$4.510.4%9.5%HK$2.7bHK$7.45P/S94.7xS35.5%n/a
Page 1 of 4